SCHEMBL23317181

SCHEMBL23317181

CC(=O)Nc1nc(F)c(CN2CC3(Cc4cc(=O)n(C)cc4O3)CC2C)s1

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 9/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23317065 1.00 OGA (0.40) OGA
SCHEMBL23305601 1.00 OGA (0.40) OGA
SCHEMBL23304929 0.86 OGA (0.40) OGA
SCHEMBL23317411 0.86 OGA (0.40) OGA
SCHEMBL29914282 0.85 OGA (0.42) OGA
SCHEMBL23304733 0.85 OGA (0.42) OGA
SCHEMBL23304882 0.84 OGA (0.43) OGA
SCHEMBL23304758 0.84 OGA (0.40) OGA
SCHEMBL23304750 0.84 OGA (0.42) OGA
SCHEMBL29914281 0.84 OGA (0.40) OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021086966-A1 SPIROCYCLIC O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS BIOGEN MA INC. (US) 2021-05-06 — — WO disclosed
Send feedback